Young to Assume Chief Roles in Hematopathology

Ken H. Young, MD PhD

I am very pleased to appoint Ken H. Young, MD PhD, as Chief of Hematopathology Division and DCI Blood Cancer Pathology Service, effective January 1, 2021.

Dr. Young is an outstanding hematopathologist and an internationally known investigator in the field of blood cancer for pathologic and clinical translational research. He has extensive experience in the diagnosis of hematologic cancers, has lectured nationally and internationally on various hematology topics particularly lymphoma and myeloma pathology. He has published 217 original peer-reviewed articles and 52 review articles, many in high impact journals (Nature Clin Onc Review, JCO, Blood, JHO, Leukemia, Clinical Cancer Research). His contributions to the hematology field include the development of novel technologies, as well as molecular and genetic biomarkers for classification of blood cancer and lymphoid neoplasms. Dr. Young’s research effort in hematopathology is funded by the National Institutes of Health/National Cancer Institute (NIH/NCI). He was also the recipient of Lymphoma and Leukemia Society LLS Award, Paul Paulson Lymphoma Award, Hagemeister Lymphoma Foundation Award, Gundersen Foundation Award, Myeloma and Lymphoma Specialized Programs of Research Excellence (SPORE) Development Awards, and Lymphoma Moonshot Program Award. Dr. Young has directed clinical hematology and translational lymphoma programs and established seven lymphoma consortium programs composed of 25 medical centers in the US. The programs develop guidelines for lymphoma pathology practice and performs clinical and translational investigations using novel technologies for genomic, epigenomic and gene expression profiling studies. Dr. Young’s laboratory focuses on the mechanisms of tumor progression, cell-of-origin, molecular and genetic biomarkers, and novel therapeutic strategies in lymphoma, myeloma, and leukemia.

Please join me in congratulating Dr. Young for this important new role. We would like to thank Dr. Anand Lagoo for his many outstanding contributions over the years to build a top-notch hematopathology service. We are pleased that Dr. Lagoo will continue to offer his expertise and experience in clinical diagnosis, education and mentoring including his important roles as the Director of Flow Cytometry Laboratory and Associate Director of Pathology Residency Program for our department.

Jiaoti Huang, MD PhD
Chair